The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries.
[2] South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment with DAAs in South Korea, a high-income country.
Original Source [3]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/cost-effectiveness-scaling-hepatitis-c-screening-and-treatment-modelling-study-south
[2] http://www.indiaenvironmentportal.org.in/files/file/hepatitis-C-South-Korea.pdf
[3] https://gh.bmj.com/content/4/3/e001441
[4] http://admin.indiaenvironmentportal.org.in/category/author/jungyeon-kim
[5] http://admin.indiaenvironmentportal.org.in/category/author/markus-haacker
[6] http://admin.indiaenvironmentportal.org.in/category/author/salmaan-keshavjee-et-al
[7] http://admin.indiaenvironmentportal.org.in/category/journal/bmj-global-health
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/hepatitis
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diagnostic-methods
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-korea
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-policy
